What is the 13F Pro Quality Score for NUS?

13F Pro ranks NU SKIN ENTERPRISES, INC. (NUS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NUS's current score at https://13fpro.ai/company/NUS (free sign-up required for the full ranking).

Where does 13F Pro source NUS data?

All NU SKIN ENTERPRISES, INC. fundamentals and ownership data come directly from SEC EDGAR. NU SKIN ENTERPRISES, INC. files with the SEC under CIK 1021561. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NUS in?

NU SKIN ENTERPRISES, INC. (NUS) is classified in the Consumer Staples sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/consumer-staples.

What drives NUS's revenue?

Per NU SKIN ENTERPRISES, INC.'s latest 10-Q filed with the SEC on 2026-08-10, the biggest revenue drivers are: Nu Skin Americas ($59.8M, -18.1% YoY); Rhyz Manufacturing ($46.4M, -23.2% YoY); Mainland China ($46.0M, -13.7% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/NUS.

What are NUS's largest expenses?

NU SKIN ENTERPRISES, INC.'s latest 10-Q reports these as the largest expense items: Impairment expenses ($78.9M, vs. $0M prior year); Provision for income taxes ($186.6M, vs. $6.3M prior year); Selling expenses ($107.9M, vs. $128.2M prior year). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 30, 2026).

How often is NUS research updated on 13F Pro?

NUS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

NU SKIN ENTERPRISES, INC.(NUS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Consumer Staples →NYSEsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1021561 NUS stock profile & AI dashboard →

13F Pro Quality Score

22.9/100

Rank #2,740 of 2,962 stocks

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

5.7/100

Profitability

15.7/100

Balance Sheet

12.2/100

Earnings Quality

14.5/100

Free Cash Flow

28.9/100

Institutional Flow

19.6/100

Revenue Scale

56.1/100

Dilution Risk

44.0/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why NUS Scores 23/100

exact factor attribution · 2026-09-11

NUS's composite is held back by revenue growth and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+0.9 pts

56th pct

Shareholder dilution

-0.3 pts

44th pct

Institutional flow

-1.5 pts

20th pct

Earnings growth

-1.7 pts

16th pct

Free cash flow

-3.2 pts

29th pct

Earnings quality

-3.5 pts

15th pct

Capital efficiency

-3.8 pts

12th pct

Profitability

-5.1 pts

16th pct

Revenue growth

-8.9 pts

6th pct

Latest change (2026-08-11): 53 → 44 · ↓ Capital efficiency 88→69; ↓ Profit margin 77→65

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

Unusual Activity in NUS

Events flagged as statistical outliers against NUS's own multi-year baseline — not fixed dollar thresholds.

Score shock2026-08-11
NUS quality score dropped 9 points (53→44) on a new filing
View source filing →

NUS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for NU SKIN ENTERPRISES, INC. (NUS), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores NUS at 22.9/100 on a 32-signal composite quality model, placing it at rank #2,740 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (5.7) and balance sheet strength (12.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), NU SKIN ENTERPRISES, INC. reports quarterly revenue of $320.1M, net income of $-249.8M, free cash flow of $5.0M. Top institutional holders of NUS by reported 13-F value include BlackRock, AMERICAN CENTURY COMPANIES, Coppell Advisory Solutions, based on the most recent SEC filings. NUS trades on the NYSE exchange and files with the SEC under CIK 1021561. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NUS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NU SKIN ENTERPRISES, INC. directly from SEC EDGAR. NU SKIN ENTERPRISES, INC.'s 13F Pro composite quality score has ranged between 23 and 58 since 2021, currently 22.9 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

What's Driving NUS's Business? Latest 10-Q Breakdown

✓ 35/35 datapoints verified

AI-extracted from NU SKIN ENTERPRISES, INC.'s 10-Q filed 2026-08-10 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revenue fell 17.1% YoY to $320.1M, driven by macroeconomic headwinds across all geographies; $78.9M goodwill impairment and $167.5M tax valuation allowance led to $(249.8)M net loss.

Biggest Revenue Drivers

Nu Skin Americas$59.8M-18.1% YoY

Continued decline in North America markets; switching costs from Prysm iO adoption; negative FX impact of 2.3%.

Rhyz Manufacturing$46.4M-23.2% YoY

Challenging comparison with strong prior year; customer order delays from tariff and economic uncertainty.

Biggest Revenue Drivers

Total revenue: $320.1M-17.1% YoY

Nu Skin Americas$59.8M-18.1% YoY

Continued decline in North America markets; switching costs from Prysm iO adoption; negative FX impact of 2.3%.

Rhyz Manufacturing$46.4M-23.2% YoY

Challenging comparison with strong prior year; customer order delays from tariff and economic uncertainty.

Mainland China$46.0M-13.7% YoY

Continued macroeconomic challenges; shift of consumer demand to online marketplaces; offset by 5.0% favorable FX.

Southeast Asia/Pacific$43.3M-14.9% YoY

Slowing momentum from general macroeconomic factors; pre-market activities in India; 1.4% favorable FX benefit.

Japan$38.1M-14.4% YoY

Consumer inflationary pressures depressing spending; offset partially by 8.8% negative FX impact.

Largest Expense Items

Impairment expenses$78.9Mvs. $0M prior year

Goodwill impairment on Manufacturing reporting unit due to stock price decline and manufacturing forecast deterioration.

Provision for income taxes$186.6Mvs. $6.3M prior year

$167.5M valuation allowance on U.S. deferred tax assets due to cumulative losses over past three years.

Selling expenses$107.9Mvs. $128.2M prior year

Higher selling expense percentage from sales compensation plan enhancements and Prysm iO transition incentives.

General and administrative expenses$90.8Mvs. $106.7M prior year

$8.6M labor expense reduction from lower incentive compensation; $2.5M software contract savings from cost management.

Margins: Gross margin as percentage of revenue decreased to 68.2% (from 68.8% prior year) due to Manufacturing segment pressure, though core Nu Skin gross margin improved 0.2 percentage points. Operating margin deteriorated sharply to negative 18.5% from positive 8.0%, driven primarily by the $78.9M goodwill impairment charge.

Watch Items from the Filing

$167.5M valuation allowance established on U.S. deferred tax assets in Q2 2026; cumulative U.S. losses over past three years deemed more likely than not to be unrealizable.
Operating loss of $(59.3)M in Q2 2026 vs. operating income of $30.8M in prior year; segment contribution declined 28% YoY to $60.0M.
Customers, Paid Affiliates, and Sales Leaders all declined 14%, 8%, and 9% YoY respectively; continued macroeconomic headwinds and consumer spending weakness across all major markets.
Manufacturing segment recorded $(0.6)M segment contribution vs. $3.7M prior year; includes $78.9M goodwill impairment reflecting significant asset value deterioration.
India pre-market launch delayed from 2026 to first half 2027; company identified need to simplify operating model; expenses incurred for preparation included in Southeast Asia/Pacific segment.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$320.1M

Net Income

Q2 2026

$-249.8M

Free Cash Flow

Q2 2026

$5.0M

ROIC

Q2 2026

-31.4%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-14.3% YoY

$1.49BFY 2025

FY22 $2.23BFY23 $1.97BFY24 $1.73BFY25 $1.49B

Net Income

+209.3% YoY

$160.2MFY 2025

FY22 $104.8MFY23 $8.6MFY24 $-146.6MFY25 $160.2M

Operating Income

+143.4% YoY

$65.8MFY 2025

FY22 $110.8MFY23 $48.3MFY24 $-151.6MFY25 $65.8M

EPS (Diluted)

+207.8% YoY

$3.18FY 2025

FY22 $2.07FY23 $0.17FY24 $-2.95FY25 $3.18

Total Assets

-4.3% YoY

$1.41BFY 2025

FY22 $1.82BFY23 $1.81BFY24 $1.47BFY25 $1.41B

Total Debt

-43.0% YoY

$224.2MFY 2025

FY22 $402.5MFY23 $503.0MFY24 $393.6MFY25 $224.2M

Op. Cash Flow

-28.2% YoY

$80.3MFY 2025

FY22 $108.1MFY23 $118.6MFY24 $111.7MFY25 $80.3M

Free Cash Flow

-34.4% YoY

$46.0MFY 2025

FY22 $49.0MFY23 $60.1MFY24 $70.2MFY25 $46.0M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.49B -14.3%	$1.73B -12.0%	$1.97B -11.5%	$2.23B -17.4%	$2.70B +4.4%	$2.58B
Net Income	$160.2M +209.3%	$-146.6M -1805.6%	$8.6M -91.8%	$104.8M -28.9%	$147.3M -23.0%	$191.4M
Operating Income	$65.8M +143.4%	$-151.6M -414.0%	$48.3M -56.5%	$110.8M -52.6%	$234.0M -9.2%	$257.6M
EPS (Diluted)	$3.18 +207.8%	$-2.95 -1835.3%	$0.17 -91.8%	$2.07 -27.6%	$2.86 -21.2%	$3.63
Total Assets	$1.41B -4.3%	$1.47B -18.7%	$1.81B -0.8%	$1.82B -4.5%	$1.91B -2.6%	$1.96B
Total Debt	$224.2M -43.0%	$393.6M -21.8%	$503.0M +25.0%	$402.5M +7.0%	$376.3M +12.2%	$335.4M
Operating Cash Flow	$80.3M -28.2%	$111.7M -5.8%	$118.6M +9.8%	$108.1M -23.7%	$141.6M -62.7%	$379.1M
Free Cash Flow	$46.0M -34.4%	$70.2M +16.6%	$60.1M +22.7%	$49.0M -32.8%	$73.0M -76.9%	$315.3M

Get alerted when NUS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NU SKIN ENTERPRISES, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NUS

BlackRock, Inc.
$22.8M4,315,878 sh
AMERICAN CENTURY COMPANIES INC
$12.2M2,301,308 sh
Coppell Advisory Solutions LLC
$11.3M235 sh
VANGUARD CAPITAL MANAGEMENT LLC
$10.8M2,049,641 sh
ACADIAN ASSET MANAGEMENT LLC
$10.3M1,953,174 sh
DIMENSIONAL FUND ADVISORS LP
$9.5M1,796,745 sh
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
$9.5M1,794,608 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$9.2M1,736,856 sh
RENAISSANCE TECHNOLOGIES LLC
$8.5M1,607,692 sh
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$7.7M1,452,937 sh

Fund	Value	Shares
BlackRock, Inc.	$22.8M	4,315,878
AMERICAN CENTURY COMPANIES INC	$12.2M	2,301,308
Coppell Advisory Solutions LLC	$11.3M	235
VANGUARD CAPITAL MANAGEMENT LLC	$10.8M	2,049,641
ACADIAN ASSET MANAGEMENT LLC	$10.3M	1,953,174
DIMENSIONAL FUND ADVISORS LP	$9.5M	1,796,745
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	$9.5M	1,794,608
VANGUARD PORTFOLIO MANAGEMENT LLC	$9.2M	1,736,856
RENAISSANCE TECHNOLOGIES LLC	$8.5M	1,607,692
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$7.7M	1,452,937

Companies Similar to NUS

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

MED

MEDIFAST INC

AI score

Similar quality profile · 5 shared holders

SummerHaven Investment Management, LLC Atom Investors LP Susquehanna Portfolio Strategies, LLC

EPC

EDGEWELL PERSONAL CARE Co

AI score

Similar quality profile · 5 shared holders

SummerHaven Investment Management, LLC Cambria Investment Management, L.P.Susquehanna Portfolio Strategies, LLC

BGS

B&G Foods, Inc.

AI score

Similar quality profile · 5 shared holders

CastleKnight Management LP Atom Investors LP LSV ASSET MANAGEMENT

HAIN

HAIN CELESTIAL GROUP INC

AI score

Similar quality profile · 4 shared holders

CastleKnight Management LP JACOBS LEVY EQUITY MANAGEMENT, INC Point72 Asia (Singapore) Pte. Ltd.

MGPI

MGP INGREDIENTS INC

AI score

Similar quality profile · 4 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC SummerHaven Investment Management, LLC Abel Hall, LLC

SMPL

Simply Good Foods Co

AI score

Similar quality profile · 4 shared holders

CastleKnight Management LP LSV ASSET MANAGEMENT AIGEN INVESTMENT MANAGEMENT, LP

DNUT

Krispy Kreme, Inc.

AI score

Similar quality profile · 3 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Susquehanna Portfolio Strategies, LLC Abel Hall, LLC

WKC

WORLD KINECT CORP

AI score

Similar quality profile · 9 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC MARTINGALE ASSET MANAGEMENT L P SummerHaven Investment Management, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Consumer Staples Companies

View all Consumer Staples →

ABEV

AMBEV S.A.

ABVE

Above Food Ingredients Inc.

ACI

Albertsons Companies, Inc.

ADM

Archer-Daniels-Midland Co

AFRI

Forafric Global PLC

AGCC

Agencia Comercial Spirits Ltd.

AGRO

Adecoagro S.A.

AGRZ

Agroz Inc.

Put NUS on your watchlist

Track score changes the day NU SKIN ENTERPRISES, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NUS a good stock to buy?

13F Pro's AI-powered analysis of NU SKIN ENTERPRISES, INC. (NUS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NUS are available on the NUS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NUS is classified as a small company.

Which hedge funds own NUS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NUS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NU SKIN ENTERPRISES, INC.'s investment landscape.